ASX
Clinuvel Pharmaceuticals Limited
CUV:ASX•Healthcare
Sensitive ASX Announcement
Clinuvel to evaluate SCENESSE as therapy in vitiligo
Published: 25/08/10, 08:35am (AEST)•3 pages